China Universal Asset Management Company’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $284K | Sell |
4,349
-16
| -0.4% | -$1.04K | 0.03% | 283 |
|
|
2025
Q1 | $292K | Sell |
4,365
-92
| -2% | -$6.16K | 0.03% | 286 |
|
|
2024
Q4 | $246K | Buy |
4,457
+412
| +10% | +$22.8K | 0.02% | 313 |
|
|
2024
Q3 | $241K | Buy |
4,045
+1,582
| +64% | +$94.4K | 0.03% | 282 |
|
|
2024
Q2 | $157K | Sell |
2,463
-1,570
| -39% | -$100K | 0.02% | 268 |
|
|
2024
Q1 | $279K | Buy |
4,033
+1,666
| +70% | +$115K | 0.04% | 250 |
|
|
2023
Q4 | $131K | Buy |
2,367
+1,854
| +361% | +$102K | 0.03% | 251 |
|
|
2023
Q3 | $29.8K | Buy |
513
+248
| +94% | +$14.4K | 0.01% | 268 |
|
|
2023
Q2 | $14.3K | Buy |
265
+29
| +12% | +$1.56K | ﹤0.01% | 295 |
|
|
2023
Q1 | $9.37K | Buy |
236
+58
| +33% | +$2.3K | ﹤0.01% | 299 |
|
|
2022
Q4 | $7.16K | Buy |
+178
| New | +$7.16K | ﹤0.01% | 259 |
|